NR 507 – Advanced Pathophysiology
Final Exam Prep Question Bank
Latest 2026/2027 Edition
100 Original Practice Questions & Detailed Rationales
For independent exam preparation and self-assessment purposes.
,How to Use This Question Bank
This resource contains 100 original, graduate-level multiple-choice questions covering the major content
domains of Advanced Pathophysiology, including cellular adaptation, immune and autoimmune disorders,
fluid/electrolyte and acid-base balance, and cardiovascular, respiratory, endocrine, neurological, renal,
gastrointestinal, hematologic, musculoskeletal, and infectious disease pathophysiology. Topics are
intentionally interspersed rather than grouped by body system to simulate a comprehensive final
examination experience.
Each question includes four answer choices, a bolded correct answer, and an italicized rationale
explaining why the correct answer is best and why the distractors are less appropriate. Work through the
questions independently before reviewing the rationale, and use missed questions to guide focused review
of the underlying pathophysiologic concept.
,Question 1
A 68-year-old man with a 40-pack-year smoking history presents with chronic productive cough and
exertional dyspnea. Spirometry reveals an FEV1/FVC ratio of 0.58 that does not improve significantly
with bronchodilator administration. Which pathophysiologic process best explains this finding?
A. Reversible bronchospasm due to mast cell degranulation
B. Irreversible airflow limitation from airway remodeling and loss of elastic recoil
C. Restrictive lung disease from pulmonary fibrosis
D. Acute inflammatory bronchiolar edema
Correct Answer: B
Rationale: COPD is characterized by fixed airflow obstruction resulting from chronic inflammation, airway
remodeling, and destruction of alveolar elastic recoil (emphysema), which is why bronchodilator response is
minimal. Reversible bronchospasm (A) describes asthma. Restrictive disease (C) would show a reduced FVC
with a normal or increased FEV1/FVC ratio, not a decreased one. Acute bronchiolar edema (D) does not
account for the fixed, chronic obstructive pattern.
Question 2
A 55-year-old woman with type 2 diabetes has a random glucose of 410 mg/dL, serum osmolality of 340
mOsm/kg, and negative serum ketones. She is lethargic but not tachypneic. Which condition is most
consistent with this presentation?
A. Diabetic ketoacidosis
B. Hyperosmolar hyperglycemic state
C. Somogyi effect
D. Alcoholic ketoacidosis
Correct Answer: B
Rationale: Hyperosmolar hyperglycemic state (HHS) occurs in type 2 diabetics with residual insulin secretion
sufficient to prevent significant ketogenesis but not hyperglycemia, producing profound hyperglycemia,
elevated osmolality, and altered mentation without ketosis or acidosis. DKA (A) would show significant
ketonemia and a metabolic acidosis with compensatory tachypnea (Kussmaul respirations). The Somogyi effect
(C) refers to rebound hyperglycemia after nocturnal hypoglycemia, not this presentation. Alcoholic
ketoacidosis (D) requires a history of alcohol use and would show ketosis.
Question 3
A nurse practitioner is explaining the mechanism of statin therapy to a patient newly diagnosed with
hyperlipidemia. Which statement best reflects the mechanism of action of HMG-CoA reductase
inhibitors?
A. They bind bile acids in the intestine to prevent cholesterol absorption
B. They inhibit the rate-limiting enzyme in hepatic cholesterol synthesis, upregulating LDL
receptor expression
C. They activate lipoprotein lipase to increase triglyceride clearance
D. They inhibit intestinal cholesterol transporters directly
, Correct Answer: B
Rationale: Statins competitively inhibit HMG-CoA reductase, the rate-limiting enzyme of cholesterol synthesis
in hepatocytes; reduced intracellular cholesterol upregulates LDL receptors, increasing hepatic clearance of
circulating LDL. Bile acid binding (A) describes bile acid sequestrants such as cholestyramine. Lipoprotein
lipase activation (C) is characteristic of fibrates. Intestinal cholesterol transporter inhibition (D) describes
ezetimibe.
Question 4
A 24-year-old woman presents with malar rash, joint pain, and fatigue. Laboratory testing reveals a
positive ANA and anti-double-stranded DNA antibody. Which underlying immunologic mechanism best
explains her renal involvement if it develops?
A. Type I hypersensitivity with IgE-mediated mast cell degranulation
B. Type II hypersensitivity with direct cytotoxic antibody binding to renal cells
C. Type III hypersensitivity with immune complex deposition activating complement in the
glomerulus
D. Type IV hypersensitivity mediated by sensitized T lymphocytes
Correct Answer: C
Rationale: Systemic lupus erythematosus nephritis results from circulating antigen-antibody (immune)
complexes depositing in the glomerular basement membrane, activating complement and recruiting
inflammatory cells, a classic type III hypersensitivity reaction. Type I (A) involves IgE and mast cells, as in
anaphylaxis. Type II (B) involves antibodies directed against cell-surface antigens, as in Goodpasture
syndrome. Type IV (D) is delayed, cell-mediated hypersensitivity, as in contact dermatitis or tuberculin
reactions.
Question 5
A 70-year-old man with a history of atrial fibrillation develops sudden left-sided weakness and slurred
speech. CT of the head shows no hemorrhage. Which mechanism most likely explains his stroke?
A. Rupture of a lenticulostriate artery causing intracerebral hemorrhage
B. Cardioembolic occlusion of a cerebral artery
C. Lacunar infarct from chronic hypertensive vessel disease
D. Vasospasm following subarachnoid hemorrhage
Correct Answer: B
Rationale: Atrial fibrillation predisposes to thrombus formation in the left atrial appendage; embolization of
this thrombus into the cerebral circulation is a common cause of acute ischemic stroke, consistent with the
sudden onset and negative CT for hemorrhage. Lenticulostriate rupture (A) would show hemorrhage on CT.
Lacunar infarcts (C) are typically due to small vessel lipohyalinosis from chronic hypertension, not atrial
fibrillation. Vasospasm (D) is a delayed complication of subarachnoid hemorrhage, not an acute presentation
like this.
Question 6
Final Exam Prep Question Bank
Latest 2026/2027 Edition
100 Original Practice Questions & Detailed Rationales
For independent exam preparation and self-assessment purposes.
,How to Use This Question Bank
This resource contains 100 original, graduate-level multiple-choice questions covering the major content
domains of Advanced Pathophysiology, including cellular adaptation, immune and autoimmune disorders,
fluid/electrolyte and acid-base balance, and cardiovascular, respiratory, endocrine, neurological, renal,
gastrointestinal, hematologic, musculoskeletal, and infectious disease pathophysiology. Topics are
intentionally interspersed rather than grouped by body system to simulate a comprehensive final
examination experience.
Each question includes four answer choices, a bolded correct answer, and an italicized rationale
explaining why the correct answer is best and why the distractors are less appropriate. Work through the
questions independently before reviewing the rationale, and use missed questions to guide focused review
of the underlying pathophysiologic concept.
,Question 1
A 68-year-old man with a 40-pack-year smoking history presents with chronic productive cough and
exertional dyspnea. Spirometry reveals an FEV1/FVC ratio of 0.58 that does not improve significantly
with bronchodilator administration. Which pathophysiologic process best explains this finding?
A. Reversible bronchospasm due to mast cell degranulation
B. Irreversible airflow limitation from airway remodeling and loss of elastic recoil
C. Restrictive lung disease from pulmonary fibrosis
D. Acute inflammatory bronchiolar edema
Correct Answer: B
Rationale: COPD is characterized by fixed airflow obstruction resulting from chronic inflammation, airway
remodeling, and destruction of alveolar elastic recoil (emphysema), which is why bronchodilator response is
minimal. Reversible bronchospasm (A) describes asthma. Restrictive disease (C) would show a reduced FVC
with a normal or increased FEV1/FVC ratio, not a decreased one. Acute bronchiolar edema (D) does not
account for the fixed, chronic obstructive pattern.
Question 2
A 55-year-old woman with type 2 diabetes has a random glucose of 410 mg/dL, serum osmolality of 340
mOsm/kg, and negative serum ketones. She is lethargic but not tachypneic. Which condition is most
consistent with this presentation?
A. Diabetic ketoacidosis
B. Hyperosmolar hyperglycemic state
C. Somogyi effect
D. Alcoholic ketoacidosis
Correct Answer: B
Rationale: Hyperosmolar hyperglycemic state (HHS) occurs in type 2 diabetics with residual insulin secretion
sufficient to prevent significant ketogenesis but not hyperglycemia, producing profound hyperglycemia,
elevated osmolality, and altered mentation without ketosis or acidosis. DKA (A) would show significant
ketonemia and a metabolic acidosis with compensatory tachypnea (Kussmaul respirations). The Somogyi effect
(C) refers to rebound hyperglycemia after nocturnal hypoglycemia, not this presentation. Alcoholic
ketoacidosis (D) requires a history of alcohol use and would show ketosis.
Question 3
A nurse practitioner is explaining the mechanism of statin therapy to a patient newly diagnosed with
hyperlipidemia. Which statement best reflects the mechanism of action of HMG-CoA reductase
inhibitors?
A. They bind bile acids in the intestine to prevent cholesterol absorption
B. They inhibit the rate-limiting enzyme in hepatic cholesterol synthesis, upregulating LDL
receptor expression
C. They activate lipoprotein lipase to increase triglyceride clearance
D. They inhibit intestinal cholesterol transporters directly
, Correct Answer: B
Rationale: Statins competitively inhibit HMG-CoA reductase, the rate-limiting enzyme of cholesterol synthesis
in hepatocytes; reduced intracellular cholesterol upregulates LDL receptors, increasing hepatic clearance of
circulating LDL. Bile acid binding (A) describes bile acid sequestrants such as cholestyramine. Lipoprotein
lipase activation (C) is characteristic of fibrates. Intestinal cholesterol transporter inhibition (D) describes
ezetimibe.
Question 4
A 24-year-old woman presents with malar rash, joint pain, and fatigue. Laboratory testing reveals a
positive ANA and anti-double-stranded DNA antibody. Which underlying immunologic mechanism best
explains her renal involvement if it develops?
A. Type I hypersensitivity with IgE-mediated mast cell degranulation
B. Type II hypersensitivity with direct cytotoxic antibody binding to renal cells
C. Type III hypersensitivity with immune complex deposition activating complement in the
glomerulus
D. Type IV hypersensitivity mediated by sensitized T lymphocytes
Correct Answer: C
Rationale: Systemic lupus erythematosus nephritis results from circulating antigen-antibody (immune)
complexes depositing in the glomerular basement membrane, activating complement and recruiting
inflammatory cells, a classic type III hypersensitivity reaction. Type I (A) involves IgE and mast cells, as in
anaphylaxis. Type II (B) involves antibodies directed against cell-surface antigens, as in Goodpasture
syndrome. Type IV (D) is delayed, cell-mediated hypersensitivity, as in contact dermatitis or tuberculin
reactions.
Question 5
A 70-year-old man with a history of atrial fibrillation develops sudden left-sided weakness and slurred
speech. CT of the head shows no hemorrhage. Which mechanism most likely explains his stroke?
A. Rupture of a lenticulostriate artery causing intracerebral hemorrhage
B. Cardioembolic occlusion of a cerebral artery
C. Lacunar infarct from chronic hypertensive vessel disease
D. Vasospasm following subarachnoid hemorrhage
Correct Answer: B
Rationale: Atrial fibrillation predisposes to thrombus formation in the left atrial appendage; embolization of
this thrombus into the cerebral circulation is a common cause of acute ischemic stroke, consistent with the
sudden onset and negative CT for hemorrhage. Lenticulostriate rupture (A) would show hemorrhage on CT.
Lacunar infarcts (C) are typically due to small vessel lipohyalinosis from chronic hypertension, not atrial
fibrillation. Vasospasm (D) is a delayed complication of subarachnoid hemorrhage, not an acute presentation
like this.
Question 6
